Synova nets 16.1x on Kinapse sale
The sale of the life sciences outsourcing business to HgCapital follows the successful close of Synova Capital Fund III on its £250m hard-cap.
1 February 2016•2 mins read
The sale of the life sciences outsourcing business to HgCapital follows the successful close of Synova Capital Fund III on its £250m hard-cap.